The latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

While companies haven’t disclosed the exact terms of the settlements, Medtronic has begun educating physicians about the shortcomings of its devices and providing QR codes on its devices that ...

A former Medtronic consultant received an 18-month prison sentence this week for his role in a scheme linked to the $1.6 billion acquisition of an Israeli medical device company in 2018.

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

(Courtesy of Medtronic) At the time, pacemakers were “crude devices,” with wires coming out of the person ... exclusive U.S.

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

A replay of the webcast will be available on the Events section of the Orchestra BioMed website for 90 days following the presentation.

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...